No long-term evidence of hyporesponsiveness following the use of pneumococcal conjugate vaccine in children previously immunised with pneumococcal polysaccharide vaccine

BACKGROUND: A randomised controlled trial in Fiji examined the immunogenicity and impact on nasopharyngeal carriage following 0, 1, 2 or 3 doses of pneumococcal conjugate vaccine (PCV7) in infancy followed by 23-valent pneumococcal polysaccharide (23vPPV) vaccine at 12 months of age. At 18 months of...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Allergy Clin Immunol
Hlavní autoři: Licciardi, Paul V, Toh, Zheng Quan, Clutterbuck, Elizabeth A, Balloch, Anne, Marimla, Rachel A, Tikkanen, Leena, Lamb, Karen E, Bright, Kathryn J, Rabuatoka, Uraia, Tikoduadua, Lisi, Boelsen, Laura K, Dunne, Eileen M, Satzke, Catherine, Cheung, Yin Bun, Pollard, Andrew J, Russell, Fiona M, Mulholland, Edward K
Médium: Artigo
Jazyk:Inglês
Vydáno: 2016
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4899320/
https://ncbi.nlm.nih.gov/pubmed/26825000
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jaci.2015.12.1303
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky